Glucose Amplifies Fatty Acid-Induced Endoplasmic Reticulum Stress in Pancreatic β-Cells via Activation of mTORC1 by Bachar, Etti et al.
Glucose Amplifies Fatty Acid-Induced Endoplasmic
Reticulum Stress in Pancreatic b-Cells via Activation of
mTORC1
Etti Bachar, Yafa Ariav, Mali Ketzinel-Gilad, Erol Cerasi, Nurit Kaiser, Gil Leibowitz*
Endocrinology and Metabolism Service, Department of Medicine, Hadassah - Hebrew University Medical Center, Jerusalem, Israel
Abstract
Background: Palmitate is a potent inducer of endoplasmic reticulum (ER) stress in b-cells. In type 2 diabetes, glucose
amplifies fatty-acid toxicity for pancreatic b-cells, leading to b-cell dysfunction and death. Why glucose exacerbates b-cell
lipotoxicity is largely unknown. Glucose stimulates mTORC1, an important nutrient sensor involved in the regulation of
cellular stress. Our study tested the hypothesis that glucose augments lipotoxicity by stimulating mTORC1 leading to
increased b-cell ER stress.
Principal Findings: We found that glucose amplifies palmitate-induced ER stress by increasing IRE1a protein levels and
activating the JNK pathway, leading to increased b-cell apoptosis. Moreover, glucose increased mTORC1 activity and its
inhibition by rapamycin decreased b-cell apoptosis under conditions of glucolipotoxicity. Inhibition of mTORC1 by
rapamycin did not affect proinsulin and total protein synthesis in b-cells incubated at high glucose with palmitate. However,
it decreased IRE1a expression and signaling and inhibited JNK pathway activation. In TSC2-deficient mouse embryonic
fibroblasts, in which mTORC1 is constitutively active, mTORC1 regulated the stimulation of JNK by ER stressors, but not in
response to anisomycin, which activates JNK independent of ER stress. Finally, we found that JNK inhibition decreased b-cell
apoptosis under conditions of glucolipotoxicity.
Conclusions/Significance: Collectively, our findings suggest that mTORC1 mediates glucose amplification of lipotoxicity,
acting through activation of ER stress and JNK. Thus, mTORC1 is an important transducer of ER stress in b-cell
glucolipotoxicity. Moreover, in stressed b-cells mTORC1 inhibition decreases IRE1a protein expression and JNK activity
without affecting ER protein load, suggesting that mTORC1 regulates the b-cell stress response to glucose and fatty acids by
modulating the synthesis and activity of specific proteins involved in the execution of the ER stress response. This novel
paradigm may have important implications for understanding b-cell failure in type 2 diabetes.
Citation: Bachar E, Ariav Y, Ketzinel-Gilad M, Cerasi E, Kaiser N, et al. (2009) Glucose Amplifies Fatty Acid-Induced Endoplasmic Reticulum Stress in Pancreatic b-
Cells via Activation of mTORC1. PLoS ONE 4(3): e4954. doi:10.1371/journal.pone.0004954
Editor: Kathrin Maedler, University of Bremen, Germany
Received November 6, 2008; Accepted February 27, 2009; Published March 23, 2009
Copyright:  2009 Bachar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by a grant from the Israel Science foundation to Gil Leibowitz and Nurit Kaiser. The funder had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The Israel Science Foundation, an Israeli National non-profit organization and a major source of competitive grant funding, supported
part of the cost involved in performing the reseach. The Foundation was not involved in the decision to submit the work for publication.
* E-mail: gleib@hadassah.org.il
Introduction
In type 2 diabetes mellitus (T2DM), elevated blood glucose and
free-fatty acids (FFAs) induce b-cell dysfunction and apoptosis
leading to exacerbation and progression of diabetes, a process
called glucolipotoxicity [1]. High levels of saturated but not
monounsaturated fatty acids were reported to increase b-cell
apoptosis in rat and human islets [2,3,4,5]. However, the toxic
effect of FFAs on the pancreatic b-cells, originally termed
lipotoxicity, gains pathological significance mainly under the in
vivo hyperglycemic state [6,7]. Thus, glucose seems to be an
important amplifier of lipotoxicity. The mechanisms underlying
this effect of glucose are not entirely clear.
There is ample evidence that palmitate induces b-cell
dysfunction and apoptosis via activation of ER stress [8,9,10,11],
probably due to alteration of b-cell calcium fluxes and down-
regulation of carboxypeptidase E [12], which perturbs the folding
and maturation of secreted and membrane-bound proteins in the
ER. This activates a complex signaling network called the
unfolded protein response (UPR) aimed at adaptation and
restoration of normal ER function, pursued by translation
attenuation, degradation of misfolded proteins and increased
protein folding capacity through augmented transcription of ER
chaperones, such as BIP. When the UPR fails to restore adequate
ER function it turns on signaling pathways leading to apoptosis
[11,13,14].
The UPR involves three major signaling pathways initiated by
three ER transmembrane sensor proteins: IRE1 (inositol requiring
ER-to nucleus signal kinase 1), the pancreatic ER kinase PERK
(double stranded RNA-activated protein kinase-like ER-associated
kinase) and ATF6 (activating transcription factor 6) [15,16,17].
IRE1 activates the c-Jun N-terminal kinase (JNK) pathway; its
sustained activation leads to apoptosis [18]. In addition, IRE1
cleaves the mRNA of the X-box binding protein-1 (Xbp-1)
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regulator of ER folding capacity [19,20]. Activation of PERK
leads to phosphorylation of eukaryotic translation initiation factor
2 alpha (eIF2a) leading to attenuation of translation under ER
stress conditions [21]. Activation of the PERK-eIF2a and ATF6
pathways may induce apoptosis through the transcriptional
activation of the CCAAT/enhancer binding protein homologous
protein (CHOP) gene [22]. Collectively, inducers of ER stress
cause apoptosis through activation of JNK and CHOP.
The mammalian target of rapamycin (mTOR), a conserved
serine/threonine kinase, functions as an important nutrient sensor;
its downstream effectors regulate protein translation and cell
growth, proliferation and survival [23,24]. mTOR exists in two
distinct complexes: a rapamycin-sensitive complex called mam-
malian target of rapamycin complex 1 (mTORC1), which includes
the regulatory associated protein of mTOR (raptor) and mLST8/
GbL, and in a rapamycin-resistant complex, mammalian target of
rapamycin complex 2 (mTORC2) with rapamycin insensitive
companion of mTOR (rictor), mLST8/GbL and Sin1 [25].
Exposure of b-cells to hyperglycemia in vivo and in vitro results in
marked activation of mTORC1, which induces phosphorylation of
ribosomal S6 kinases (S6K1 and S6K2) and the translation
inhibitor factor, eukaryotic initiation factor 4E binding protein 1
(4EBP1) [26]. S6K phosphorylates the 40S ribosomal protein S6,
the protein synthesis initiation factor 4B (eIF4B) and the
elongation factor 2 kinase (eEF2K) [27]. 4EBP1 phosphorylation
releases eIF4E from 4EBP1, allowing cap-dependent translation
initiation [26,28]. The activation of S6K1/2 and the release of
eIF4 by mTORC1 stimulate ribosomal biogenesis and mRNA
translation, hence augment protein biosynthesis.
It appears from the above that mTORC1 stimulation of protein
synthesis might counteract the adaptive attenuation of protein
synthesis under conditions of ER stress. Herein we tested the
hypothesis that glucose augments lipotoxicity by stimulating
mTORC1, thus leading to increased FFA-induced ER stress,
with augmentation of b-cell apoptosis as a consequence.
Results
The role of mTORC1 in glucose- and palmitate-induced
b-cell apoptosis
INS-1E b-cells were treated with 0.5 mmol/l palmitate at 3.3
and 22.2 mmol/l glucose for 16 h. Apoptosis was quantified using
an ELISA assay for cytosolic oligonucleosome content indicative of
apoptosis-induced DNA degradation (Figure 1A). At 3.3 mmol/l
glucose, palmitate had a small, non-significant effect on b-cell
apoptosis; the tendency for apoptosis was 1.4-fold higher than in
untreated cells incubated at 0.5% BSA (w/v). Incubation of INS-
1E cells at 22.2 mmol/l sensitized the b-cells to the toxic effect of
palmitate: the apoptotic rate of INS-1E b-cells treated with
palmitate was now 2.1- and 2.9-fold higher than that of palmitate-
treated cells at 3.3 mmol/l glucose and untreated controls at
22.2 mmol/l glucose, respectively.
To study the role of mTORC1 in glucose-induced palmitate
toxicity we used the mTORC1 inhibitor rapamycin. Rapamycin
prevented b-cell apoptosis in response to palmitate both at low and
high glucose (Figure 1A). Western blot analysis showed that
22.2 mmol/l glucose did not affect caspase 3 cleavage. Palmitate
modestly increased cleaved caspase 3 at 3.3 mmol/l glucose;
whereas, it markedly augmented caspase 3 activation at
22.2 mmol/l glucose (Figure 1B). Consistent with the anti-
apoptotic effect of rapamycin in b-cells exposed to glucolipotoxi-
city conditions, we found that rapamycin attenuated caspase 3
cleavage in INS-1E cells incubated at 22.2 mmol/l glucose with
palmitate (Figure 1B). Rapamycin did not decrease the rate of b-
cell proliferation (Figure S1). Taken together, our data suggest that
mTORC1 is involved in palmitate-induced b-cell apoptosis and its
amplification by glucose.
Glucose and palmitate effects on mTORC1 signaling
Since mTORC1 may function as an important modulator of
glucolipotoxicity-induced b-cell apoptosis, we studied the effects of
high glucose and palmitate on its signaling in b-cells. Glucose
increased S6 and 4EBP1 phosphorylation (Figure 2), showing as
expected, that glucose activates mTORC1 signaling. Palmitate
partially reduced mTORC1 activation by high glucose, as seen by
reduced S6 and 4EBP1 phosphorylation levels. However,
mTORC1 activity was higher in b-cells treated with palmitate at
22.2 mmol/l than at 3.3 mmol/l glucose. Rapamycin completely
abolished S6 phosphorylation and partially decreased 4EBP1
phosphorylation under all conditions, indicating that rapamycin
efficiently inhibited mTORC1 in INS-1E cells exposed to high
glucose and palmitate.
The role of mTORC1 in glucose- and palmitate-induced
ER stress
Palmitate induces b-cell apoptosis through activation of ER
stress [8,9,10,11]. We studied whether glucose increased
Figure 1. Effect of mTORC1 inhibition by rapamycin on glucose
and palmitate-induced b-cell apoptosis. INS-1E cells were incu-
bated at 3.3 and 22.2 mmol/l glucose with 0.5% BSA with and without
0.5 mmol/l palmitate and 50 nmol/l rapamycin for 16 h. Apoptosis was
assessed using the Cell Death ELISA
PLUS assay (Roche Diagnostics) (A)
and by Western blot for cleaved caspase 3 (B). Results are expressed as
means6SE of 4 individual experiments, each performed in triplicates
(A). A representative gel of 3 individual experiments showing the
expression of cleaved and uncleaved caspase 3 is presented (B). **
p,0.01,
‘ p,0.001 for the difference between the indicated groups.
doi:10.1371/journal.pone.0004954.g001
ER Stress in Beta-Cells
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response. Following a 4-h incubation, palmitate stimulated
different ER stress markers including CHOP, phospho-PERK,
c-Jun, JNK and eIF2a (Figure 3A). c-Jun and JNK phosphory-
lation was higher at 22.2 mmol/l than at 3.3 mmol/l glucose.
Importantly, the phosphorylation of these kinases was higher in
palmitate-treated INS-1E cells at 22.2 mmol/l compared to
3.3 mmol/l glucose. However, the expression of the other ER
stress markers was similar or only modestly increased in
palmitate-treated INS-1E cells at 22.2 vs 3.3 mmol/l glucose
(Figure 3A). Thus, glucose amplifies the early activation of the
JNK pathway by palmitate with a small effect on the activation of
other ER stress parameters. At 16 h, high glucose markedly
increased palmitate activation of CHOP, PERK, c-Jun and JNK.
The induction of these stress markers was decreased by
rapamycin (Figure 3A&B).
P. obesus is an animal model of type 2 diabetes characterized by
increased susceptibility to glucolipotoxicity-induced b-cell apopto-
sis [29]. Incubation of P. obesus islets at 22.2 mmol/l glucose
increased palmitate-induced JNK phosphorylation compared to
islets at 3.3 mmol/l glucose (Figure 3C). However, contrasting the
amplifying effect of glucose on palmitate-induced PERK phos-
phorylation in INS-1E cells, in P. obesus islets glucose decreased
PERK phoshorylation (Figure 3C). Thus, PERK phosphorylation
is differentially regulated by glucose in the b-cell line and in P.
obesus islets. Similar to INS-1E cells, rapamycin decreased the
phosphorylation of JNK, c-Jun and PERK in islets under
conditions of glucolipotoxicity.
In summary, rapamycin decreased the activation of ER stress
markers by palmitate and attenuated the enhancement of ER
stress and apoptosis by glucose.
The early activation of the JNK/c-Jun pathway by glucose in
INS-1E cells and the finding that glucose increases palmitate-
induced JNK phosphorylation also in islets led us to study further
the role of JNK in b-cell ER stress and apoptosis under conditions
of glucolipotoxicity.
Regulation of the IRE1a-JNK pathway under conditions
of glucolipotoxicity
JNK is a direct target of IRE1a; therefore, we studied the effects
of glucose, palmitate and rapamycin on IRE1a expression and
function. IRE1a protein level was higher in INS-1E cells incubated
at 22.2 mmol/l than at 3.3 mmol/l glucose. Palmitate increased
IRE1a protein level at both glucose concentrations, whereas
rapamycin decreased its expression (Figure 4A–B). The expression
of other peptides involved in the regulation of ER stress, such as
JNK and eIF2a was similar under all conditions (Figure 3A),
indicating that glucose and palmitate stimulation of protein
expression is specific to IRE1a. The time-course of IRE1a protein
levels in b-cells treated with high glucose and palmitate showed that
high glucose increased IRE1a expression in b-cells treated with or
without palmitate for 8–16 h (Figure 4A–B and Figure S2A). This
was paralleled by changes in IRE1a and JNK/c-Jun phosphory-
lation (Figure 4A and Figure 3). Next, we studied the effects of
nutrients and rapamycin on IRE1a gene expression (Figure 4C and
Figure S2B). IRE1a mRNA levels were similar under all treatment
conditions, indicating that nutrients and mTORC1 regulate IRE1a
protein expression at the post-tanscriptional level.
IRE1a functions as an endoribonuclease, which initiates the
splicing of the mRNA encoding the key transcription factor XBP-
1. Spliced Xbp-1 was not increased in palmitate-treated INS-1E
cells at 22.2 mmol/l compared to similarly treated cells at
Figure 2. Effects of glucose, palmitate and rapamycin on mTORC1 signaling in b-cells. INS-1E cells were incubated overnight in RPMI
medium containing 3.3 mmol/l glucose and 0.5% BSA without serum and then at 3.3 and 22.2 mmol/l glucose with and without 0.5 mmol palmitate
and 50 nmol/l rapamycin for 4 h. S6(Ser235/236) and 4EBP1 phosphorylation were analyzed by Western blot. (A) A representative gel showing total
and phosphorylated S6 and 4EBP1 is presented. (B) Quantification of S6 and 4EBP1 phosphorylation. Results are expressed as means6SE of 6
individual experiments. * p,0.05,
‘ p,0.001 for the difference between the indicated groups.
doi:10.1371/journal.pone.0004954.g002
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cells treated with palmitate at 22.2 mmol/l glucose (Figure 4D).
mTORC1 regulation of proinsulin and global protein
synthesis under conditions of glucolipotoxicity
Activation of mTORC1 augments protein synthesis, which may
increase the ER client protein load, leading to exacerbation of ER
stress. In b-cells, proinsulin is the most abundant protein delivered
to the ER. Therefore, we studied the effects of glucose, palmitate
and rapamycin on proinsulin and global protein synthesis in b-cells
(Figure 5–6). Culture of INS-1E cells at 22.2 mmol/l glucose
induced 1.5- and 1.7-fold increase in total protein and proinsulin
biosynthesis, respectively. Strikingly, palmitate completely abol-
ished the glucose stimulation of proinsulin and total protein
Figure 3. Effect of mTORC1 inhibition by rapamycin on glucose and palmitate-induced ER stress in b-cells and islets. INS-1E cells were
incubated at 3.3 and 22.2 mmol/l glucose with and without 0.5 mmol/l palmitate and 50 nmol/l rapamycin for 4 and 16 h; P. obesus islets were similarly
treated for 24 h. Control incubations contained 0.5% BSA. ER stress was assessed by Western blot analysis for different ER stress markers. (A) A
representative gel showing CHOP, phospho-PERK, phospho-c-Jun, phospho- and total JNK, phospho- and total eIF2a in INS-1E cells is presented. (B)
Quantification of c-Jun, JNK, and PERK phosphorylation and CHOP expression at 16 h. Results are expressed as means6SE of 4 individual experiments.
(C) A representative gel of 3 individual experiments showing phospho-c-Jun, phospho-PERK and phospho- and total JNK in P. obesus islets. * p,0.05,
‘ p,0.001for the difference betweenthe indicatedgroupsor between theindicatedgroups anduntreated controls atthe sameglucose concentration.
doi:10.1371/journal.pone.0004954.g003
ER Stress in Beta-Cells
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palmitate shuts off protein synthesis. Rapamycin decreased glucose-
stimulated proinsulin and total protein biosynthesis only by 10%
withoutaffectingprotein synthesisinpalmitate-treatedINS-1Ecells.
Effects of IRE1a inhibition by cycloheximide on ER stress
It is well established that rapamycin is an inhibitor of mRNA
translation. To further study the effects of translation inhibition on
IRE1a synthesis in stressed b-cells, INS-1E b-cells were incubated
under glucolipotoxic conditions with and without a low concentration
(0.2 mmol/l) of the translational inhibitor cycloheximide. Cyclohex-
imide prevented glucose and fatty acid augmentation of IRE1a
expression without affecting global protein synthesis in palmitate
treated cells, mimicking the effects of rapamycin (Figure 6A–B).
We then studied whether translational inhibition of IRE1a by
cycloheximide may alleviate the ER stress response in b-cells
Figure 4. Effects of glucose, palmitate and rapamycin on IRE1a expression and activity. INS-1E cells were incubated at 3.3 and 22.2 mmol/
l glucose with and without 0.5 mmol/l palmitate and 50 nmol/l rapamycin for 16 h. (A) A representative gel showing total and phospho-IRE1a. (B, C)
Quantification of IRE1a protein and mRNA levels, respectively. (D) Spliced Xbp-1 levels assessed by quantitative real-time PCR. Results are expressed
as means6SE of 4–5 individual experiments. * p,0.05,
‘ p,0.001 for the difference between the indicated groups or between the indicated groups
and untreated controls at the same glucose concentration.
doi:10.1371/journal.pone.0004954.g004
Figure 5. Effects of glucose, palmitate and rapamycin on total protein and proinsulin biosynthesis. INS-1E cells were incubated for 16 h
at 3.3 and 22.2 mmol/l glucose with 0.5% BSA with and without 0.5 mmol/l palmitate and 50 nmol/l rapamycin. The last 2 h of the incubations were
performed in KRBH-BSA buffer containing similar treatments and 10 mCi L-[2, 3, 4, 5-
3H]leucine. After a 2-h incubation at 37uC, leucine incorporation
was terminated by ice-cold wash-out in glucose-free KRBH-BSA buffer. Total protein synthesis (A) was determined by trichloroacetic acid
precipitation. Proinsulin (PI) biosynthesis (B) was determined by immunoprecipitation with anti-insulin serum. Results are expressed as means6SE of
3 individual experiments, each performed in triplicates. * p,0.05, ** p,0.01,
‘ p,0.001 for the difference between the indicated groups or between
the indicated groups and untreated controls at the same glucose concentration.
doi:10.1371/journal.pone.0004954.g005
ER Stress in Beta-Cells
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JNK, c-Jun and PERK phosphorylation, CHOP expression and
cleaved caspase 3 levels in palmitate-treated b-cells at high glucose
(Figure 6C), indicating that inhibition of translation alleviated the
stress exerted on the ß-cells through inhibition of IRE1a
expression, rather than reduction of ER protein load.
mTORC1 regulation of JNK/c-Jun phosphorylation
Glucose robustly increased the stimulation of JNK/c-Jun phos-
phorylation by palmitate. This effect was rapid and preceded the
glucoseamplification of other ER stress markers (Figure3).However,
activation of the JNK pathway is not exclusive to ER stress. To
confirm that mTORC1 regulates JNK/c-Jun activation in response
to ER stress, we studied the effect of thapsigargin, which is an ER
stressor, and that of anisomycin,which activates JNKin an ER stress-
independent manner. This was studied in TSC2-deficient mouse
embryonic fibroblasts (MEFs) and in wild-type TSC2 expressing cells.
The TSC1-2 complex, through its Rheb-GTP activity, is a critical
negative regulator of mTORC1 [30,31]; therefore the mTORC1
pathway is constitutively active in TSC2-deficient cells.
Figure 7A), indicating activation of the ER stress response. Basal
and thapsigargin-induced JNK and c-Jun phosphorylation was
higher in TSC22/2 cells than in wild-type cells. Moreover,
rapamycin decreased CHOP, JNK and c-Jun phosphorylation in
the TSC22/2 MEFs (Figure 7A). Collectively, these findings
indicate that dysregulated mTORC1 activity sensitizes cells to
JNK activation by ER stress.
Anisomycin did not increase CHOP expression (Figure 7B),
showing that it did not induce ER stress. As expected, anisomycin
markedly increased JNK and c-Jun phosphorylation in both
TSC22/2 and wild-type cells; however, rapamycin did not affect
this activation, while reducing as expected CHOP expression.
Taken together, these findings indicate that mTORC1 specifically
regulates the JNK response to ER stress.
The role of JNK in b-cell apoptosis under glucolipotoxic
conditions
We studied the role of JNK in b-cell apoptosis in response to
high glucose and palmitate. INS-1E cells were incubated at 3.3
and 22.2 mmol/l glucose with and without 0.5 mmol/l palmitate
and 20 nmol/l of the JNK inhibitor SP600125. SP600125
completely inhibited the induction of c-Jun phosphorylation by
palmitate at 3.3 mmol/l glucose. In addition, it partially inhibited
c-Jun phosphorylation in response to 22.2 mmol/l glucose with
and without palmitate (Figure 8A).
SP600125 decreased b-cell apoptosis of INS-1E cells under all
conditions, with a dramatic 60% reduction of apoptosis in cells
treated with palmitate at 22.2 mmol/l glucose (Figure 8B).
These results clearly demonstrate that JNK inhibition can
protect b-cells from glucolipotoxicity-induced apoptosis.
SP600125 did not affect PERK phosphorylation and CHOP
expression (Figure S3), indicating that its protective effect was
through inhibition of JNK without affecting other ER stress
pathways.
Figure 6. Effects of cycloheximide on IRE1a protein levels, total protein synthesis and different markers of ER stress in INS-1E cells
treated with palmitate. INS-1E cells were incubated at 3.3 and 22.2 mmol/l glucose with and without 0.5 mmol/l palmitate and 20 nmol/l
cycloheximide for 16 h. (A) IRE1a expression was analyzed by Western blot. A representative gel of 4 individual experiments is shown. (B) Total
protein synthesis was determined as described in Figure 5. Results are expressed as means6SE of 3 individual experiments, each performed in
triplicates. (C) Western blot analysis for different ER stress and apoptosis markers. A representative gel of 4 individual experiments showing CHOP,
phospho-PERK, phospho-c-Jun, phospho- and total JNK and cleaved caspase 3 is presented. * p,0.05, ** p,0.01,
‘ p,0.001 for the difference
between the indicated groups or between the indicated groups and untreated controls at the same glucose concentration.
doi:10.1371/journal.pone.0004954.g006
ER Stress in Beta-Cells
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The main findings of this study are that: 1. glucose amplifies
fatty acid-induced ER stress and apoptosis in b-cells; and 2.
mTORC1 regulates the ER stress response under conditions of
glucolipotoxicity through modulation of the IRE1a-JNK pathway
without affecting global protein or proinsulin biosynthesis.
Herein, we show for the first time that glucose is a potent
amplifier of the ER stress response to fatty acid. A previous study
by Chunha et al reported that glucose does not amplify fatty acid-
induced ER stress, contrasting our data [32]. The discrepancy
between our data and those of Chunha et al may stem from the
fact that in the previous report the expression of ER stress markers
was analyzed mainly by qPCR, whereas we analyzed the protein
levels and the phophorylation state of different mediators of the
ER stress response. We believe that our data reflect ER stress
activation more accurately, as the ER stress response is mediated
through phosphorylation and activity of peptides. In this regard, it
is of interest that the previous authors found that high glucose
sensitized INS-1E cells to the apoptotic effect of a pharmacological
inducer of ER stress [32], which may support our conclusion that
glucose is an amplifier of ER stress.
Our findings emphasize the central role of glucose activation of
the IRE1a-JNK pathway in glucolipotoxicity. This is based on
detailed analysis of IRE1a expression and phosphorylation, JNK
and c-Jun phosphorylation and Xbp-1 splicing. In our hands, the
level of spliced Xbp-1 was the least sensitive marker for IRE1a
kinase activity and did not completely overlap with the other
indicators of IRE1a activation. Consistent with our findings,
Lipson et al found that prolonged exposure of INS-1 cells to high
glucose markedly increased IRE1a phosphorylation without
affecting the level of spliced Xbp-1 [33]. Therefore, Xbp-1 should
not be used as the sole parameter for assessing IRE-1a pathway
activation.
High glucose levels markedly increase the demand on the b-cell
ER due to increased synthesis of proteins, mostly proinsulin [34].
In rat islets, acute stimulation by glucose modestly increased
several ER stress markers including spliced Xbp1, ER chaperones,
ATF3, CHOP and GADD34 [35]. In addition, both short-term
and prolonged exposure to a high glucose concentration were
shown to induce IRE1 activation in mouse islets [33,36].
However, the overall induction of ER stress by glucose is lower
Figure 7. Effects of mTORC1 on ER stress-dependent and -independent JNK activation. TSC2-deficient and wild-type mouse embryonic
fibroblasts were treated with 300 nmol/l thapsigargin for 24 h (A) or with 200 nmol/l anisomycin for 30 min (B) with and without 50 nmol/l
rapamycin, as described under Materials and Methods. JNK and c-Jun phosphorylation were analyzed by Western blot. Representative gels of 3
individual experiments showing CHOP, phoshpo-c-Jun, total and phospho-JNK are presented.
doi:10.1371/journal.pone.0004954.g007
Figure 8. Effect of JNK inhibition on glucose and palmitate-
induced b-cell apoptosis. INS-1E cells were incubated for 16 h at 3.3
and 22.2 mmol/l glucose with 0.5% BSA with and without 0.5 mmol/l
palmitate and 20 nmol/l of the JNK inhibitor SP600125. (A) Inhibition of
JNK activation was studied by Western blot for phospho-c-Jun
normalized to total JNK. A representative gel of 3 separate experiments
is shown. The effects of JNK inhibition on apoptosis was analyzed using
the apoptosis ELISA assay (B). Quantification of 3 individual experi-
ments, each performed in triplicates is shown. * p,0.05, ** p,0.01,
‘ p,0.001 for the difference between the indicated groups.
doi:10.1371/journal.pone.0004954.g008
ER Stress in Beta-Cells
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toxic conditions.
Others and we have shown that high glucose activates
mTORC1 in b-cells and islets (Figure 2) [37,38]. Importantly,
we found that inhibition of mTORC1 by rapamycin markedly
decreased the ER stress response and apoptosis under conditions
of glucolipotoxicity, indicating that mTORC1 is involved in the
regulation of nutrient-induced ER stress in b-cells.
Our results are consistent with those of Ozcan et al who found
that loss of tuberous sclerosis complex (TSC) suppressors in tumor
cells, leading to dysregulated mTOR activity, triggers the UPR
and increases apoptosis [39]. Our data extend these observations
and suggest that mTOR regulates the ER stress response to
nutrient overload in pathological metabolic states such as type 2
diabetes.
How does mTORC1 regulate the glucolipotoxic ER stress in
b-cells? We tested the hypothesis that nutrient stimulation of
mTORC1 amplifies the ER stress response by stimulating global
protein, or specifically proinsulin biosynthesis. Palmitate is a
potent suppressor of proinsulin and general protein synthesis in b-
cells (Figure 5). This is achieved by IRE1-dependent degradation
of ER-targeted mRNAs, such as proinsulin [33,36]. In addition,
PERK phosphorylates eIF2a, thereby inhibiting 80S ribosome
assembly and consequently protein biosynthesis [21]. Global
attenuation of protein biosynthesis through eIF2a paradoxically
increases the expression of some distinct proteins including the
transcription factor ATF4 [40]. It was recently shown that ATF4
induces 4EBP1, which inhibits protein synthesis and contributes
to b-cell survival during late stages of the UPR [41]. Thus,
induction of ER stress by palmitate turns on multiple pathways
aimed to attenuate protein synthesis in b-cells exposed to
glucolipotoxicity.
A recent quantitative assessment of the UPR showed that in
mammalian professional secretory cells, such as pancreatic b-cells,
translation attenuation is a critical adaptive mechanism to ER
stress, which is less important in non-secretory cells and in lower
eukaryotes [42]. In b-cells this adaptation is essential for survival
under conditions of ER stress. Translation attenuation reduces the
accumulation of unfolded proteins in the ER and the burden of
chaperones that are long-lived proteins, which may cause cell
toxicity during the recovery from stress [43].
Our study shows that in b-cells exposed to glucolipotoxic stress,
the translation attenuation mechanism is highly efficient; the rate
of protein biosynthesis was decreased to basal levels. Notably,
rapamycin did not affect total protein or proinsulin biosynthesis
under these conditions, indicating that in b-cells mTORC1
inhibition does not affect the translation attenuation induced by
FFAs. Similarly, a low concentration of cycloheximide, mimicking
the effects of rapamycin on protein synthesis at high glucose,
efficiently abolished the ER stress response to glucose and
palmitate without affecting global protein synthesis.
If this is the case, how does rapamycin reduce glucolipoxicity-
induced ER stress in b-cells?
According to our results, it seems that rapamycin may attenuate
the stress response to glucolipotoxicity by modulating the activity
of specific pathways involved in the regulation of ER stress,
notably the IRE1a-JNK pathway.
The JNK pathway is a critical mediator of fatty acid-induced
ER stress, probably through activation of Foxo1 [44]. Glucose
robustly increased JNK and c-Jun phosphorylation and amplified
their stimulation by palmitate in an mTORC1-dependent
manner. Moreover, JNK inhibition reduced b-cell apoptosis
underscoring the important role of this pathway in mediating
glucolipotoxicity-induced b-cell apoptosis.
It is important in this context, that IRE1a protein levels are
increased by glucose and palmitate, an effect that could be
prevented by rapamycin, indicating that mTORC1 is involved in
the regulation of IRE1a biosynthesis. Glucose stimulation of c-Jun
occurred early (at 4 h) and preceded the changes in IRE1a protein
expression. Therefore, at early time points, glucose, palmitate and
rapamycin may modulate JNK/c-Jun activation independent of
their effects on IRE1a expression. However, at the late stage of the
UPR (at 16 h) the changes in IRE1a protein levels are likely to be
involved in the modulation of the IRE1a-JNK pathway activation.
We cannot exclude that rapamycin induced a small decrease of
proinsulin or global protein synthesis, which was overlooked by the
assay used in this study. However, the impact of such small
inhibition of ER client protein load is most probably of a minor
significance compared to the robust effects on the IRE1a-JNK
pathway.
In summary, our data contradict the assumption that mTORC1
augments ER stress by increasing cell metabolism and protein
synthesis and suggests instead that it regulates the b-cell stress
response to glucose and fatty acids by modulating the synthesis and
activity of specific proteins involved in the execution of the ER
stress response, such as IRE1a.
Implications for the pathogenesis and treatment of type
2 diabetes
Type 2 diabetes is characterized both by insulin resistance and
decreased insulin production, i.a. due to increased b-cell apoptosis.
Sustained mTORC1 activity leading to ER stress and JNK
activation caused insulin resistance, while treatment with chemical
chaperones prevented the ER stress response and enhanced insulin
signaling in TSC-deficient cells [39]. Moreover, reducing ER
stress in ob/ob mice using these chaperones in vivo normalized
blood glucose and enhanced insulin sensitivity [45]. Several studies
suggested that nutrient overload leads to mTORC1 activation,
thereby increasing insulin resistance [46,47]. Thus, there seems to
emerge a consensus that nutrient overload causes insulin resistance
by stimulating mTORC1, leading to ER stress and increased JNK
activity. Similar mechanisms may also be operative in b-cells. It
was previously shown that activation of mTORC1 in b-cells by
high glucose or growth factors increased IRS2 degradation with b-
cell apoptosis as a consequence [37]. Thus, it is possible that
mTORC1 impairs b-cell survival in type 2 diabetes both by
increasing IRS2 degradation and by enhancing the stress response
to glucose and fatty acids. It remains to be shown whether
impaired IRS2 or IRS1 signaling in response to hyperglycemia
and possibly to FFAs is mediated through induction of ER stress in
b-cells.
Disruption of TSC2 in b-cells increased b-cell size and
proliferation, resulting in b-cell mass expansion and improved
glucose tolerance [48]. Rapamycin abolished these effects
indicating that TSC2 regulates b-cell mass in an mTORC1-
dependent manner. Moreover, we have shown that activation of
mTORC1 by glucose is important for b-cell adaptation to
hyperglycemia in type 2 diabetes: rapamycin treatment of diabetic
P. obesus markedly increased their hyperglycemia and b-cell
apoptosis [38]. This may suggest that mTORC1 has a dual effect
in the regulation of b-cell mass in type 2 diabetes: on one hand it is
required for the adaptive increase in b-cell size and proliferation
by stimulating protein synthesis; and on the other, it may increase
ER stress and apoptosis in b-cells, e.g. in response to fatty acids.
Consistent with the contention that mTORC1 has a dual role in
the regulation of b-cell mass, mice lacking TSC2 in islets exhibit a
biphasic response of their b-cell mass [49]. During early life the b-
cell mass of these mice was increased; however, at older age they
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companied by a reduction in b-cell mass. Thus, different
parameters, including the duration of mTORC1 activation, the
age of the animals and their metabolic state may influence the b-
cell response to modulation of mTORC1 activity. mTORC1 was
shown to regulate mitochondrial biogenesis and function [50] in
addition to its regulation of ER function; thus, inhibition of
mTORC1 may have various effects on different pathways
involved in cellular stress.
In summary, mTORC1 probably leads to both insulin
resistance and b-cell apoptosis under glucolipotoxic conditions
by promoting ER stress. Although inhibition of mTORC1 may
alleviate the ER stress response to glucose and fatty acids,
prolonged treatment of diabetic animals with mTORC1 inhibitors
leads to increased b-cell apoptosis and progressive hyperglycemia
[38]. The complex role of mTORC1 in the regulation of b-cell
proliferation and apoptosis, as well as in nutrient sensing and
metabolism, suggests that inhibition of mTORC1 is unlikely to
become a therapeutic approach in type 2 diabetes.
Materials and Methods
Islet isolation, b-cell line culture and experimental
protocols
Diabetes-prone, 2.5–3.5 month-old male P. obesus (Hebrew
University Colony, Harlan, Jerusalem, Israel) were fed a low-
energy (LE; 2.38 kcal/g) diet (Koffolk, Petach-Tikva, Israel),
which maintains normoglycemia (3–5 mmol/l in this species).
Islets were isolated from prediabetic, normoglycemic P. obesus by
collagenase digestion (Collagenase P; Roche Diagnostics GmbH,
Mannheim, Germany) as described [51]. The islets were used after
repeated washes with Hanks’ balanced salt solution. They were
cultured in suspension in RPMI 1640 medium (Biological
Industries, Beit-Haemek, Israel) with 10% fetal bovine serum,
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mmol/l L-
glutamine (Biological Industries) and different glucose concentra-
tions. Animal use was approved by the Institutional Animal Care
and Use Committee of the Hebrew University and the Hadassah
Medical Organization.
INS-1E b-cells were grown in RPMI 1640 medium (Biological
Industries, Beit Haemek, Israel) supplemented with 10% fetal
bovine serum, 1 mmol/l sodium pyruvate, 2 mmol/l L-glutamine,
10 mmol/l HEPES, 0.05 mmol/l 2-mercaptoethanol, 100 units/
ml penicillin and 100 mg/ml streptomycin.
To study the effects of glucose and palmitate on islet and b-cell
ER stress, P. obesus islets or INS-1E cells were incubated in RPMI
medium with 0.5% (w/v) BSA with or without 0.5 mmol/l
palmitate at 3.3 and 22.2 mmol/l glucose for different periods of
time. The palmitate-BSA solution was prepared as described [4].
Briefly, the sodium salt of palmitic acid was dissolved at a
concentration of 10 mmol/l in 11% BSA in a shaking water bath
at 37uC for 16 h. The pH of the palmitate-BSA solution was
adjusted to 7.4 with 1 N NaOH. It was then filtered through a
sterile 0.2 m filter and stored at 220uC. The palmitate-BSA
solution was diluted 1:20 in the INS-1E incubation medium
before use. The molar ratio of palmitate:BSA was 6:1. To assess
the role of mTORC1 in palmitate-induced ER stress, P. obesus
islets or INS-1E cells were treated with the mTORC1 inhibitor
rapamycin (50 nmol/l) according to the experimental protocol.
Cycloheximide (0.2 mmol/l) was used to study the effects of
protein biosynthesis inhibition on ER stress. The JNK inhibitor
SP600125 (20 nmol/l) was used to study the role of the JNK
pathway in b-cell apoptosis in response to high glucose and
palmitate.
INS-1E and islet extracts were used for analysis of mTORC1
signaling, protein biosynthesis, ER stress markers and apoptosis, as
described below. All reagents were purchased from Sigma
(Rehovot, Israel).
Anisomycin and thapsigargin treatment of TSC2
2/2
mouse embryonic fibroblasts
TSC2
2/2 and control wild-type mouse embryonic fibroblasts
were kindly provided by Dr. David J. Kwiatkowski (Harvard
Medical School, Boston). Cells were cultured in DMEM (Beit
Haemek) supplemented with 10% fetal calf serum, 2 mmol/l
glutamine, 100 units/ml penicillin and 100 mg/ml streptomycin.
The cultures were treated with 200 nmol/l anisomycin (Sigma) for
30 min, or 300 nmol/l thapsigargin (Sigma) for 24 h with and
without 50 nmol/l rapamycin. Cells treated with anisomycin and
rapamycin were pre-loaded with rapamycin for 2 h prior to the
treatment with the different inducers of JNK. MEFs extracts were
used for analysis of JNK and c-Jun phosphorylation and additional
markers of ER stress.
Western blot analysis
Protein expression and phosphorylation in INS-1E cells, P.
obesus islets and MEFs were studied by standard Western blot
analyses using antibodies against p70S6 kinase, phospho-p70S6
kinase (Thr389), S6 ribosomal protein, phospho-S6 ribosomal
protein (Ser235/236), 4EBP1 and phospho-4EBP1 (Cell Signaling
Technology, Beverly, MA). ER stress markers were assessed using
antibodies against total and phospho-IRE1a (kindly provided by
Dr. Urano, University of Massachusetts, Boston, MA), phospho-
SAPK/JNK (Thr183/Tyr185), SAPK/JNK, c-JUN, phospho-
eIF2a total and phospho-PERK (all from Cell Signaling
Technology), GADD153/CHOP and eIF2a (Santa Cruz, Bio-
technology, Santa Cruz, CA). Molecular activation of apoptosis
was assessed by measurement of cleaved caspase 3 using polyclonal
goat anti-rabbit antibody (Cell Signaling Technology). Peroxidase-
conjugated AffiniPure goat anti-rabbit from Jackson Immunor-
esearch Laboratories (West Grove, PA) was used as secondary
antibody. X-ray film densitometry was used for quantification
(ImageMaster VDS-CL, Amersham Pharmacia Biotech, UK).
Quantitative real-time RT-PCR
RNA was extracted from INS-1E cells using Trireagent (Biolab,
Jerusalem, Israel); samples of 1 mg total RNA were reverse
transcribed using Moloney murine leukemia virus reverse tran-
scriptase (Promega, Madison, WI, USA). Quantitative real time
RT-PCR (qPCR) for IRE1a and spliced Xbp1 was performed on a
Prism 7000 Sequence Detection System using the Power SYBR
Green PCR Master Mix (Applied Biosystem, Foster City, CA,
USA). All samples were analysed in triplicate and corrected for
GAPDH used as an internal control. The followingoligos wereused
for the PCR reaction: Spliced Xbp1: forward 59- GAGTCCG-
CAGCAGGTG -39, reverse 59 -GAA GAG GCA ACA GCG TCA
GA -39; Ire1a: forward59- TGTCCCACTTTG TGTCCA ATGG
-39 reverse 59 - TTGCTCTTGGCCTCTGTCTCCTT -39;
GAPDH: forward 59- AGT TCA ACG GCA CAG TCA AG -39
reverse 59 – TAC TCA GCA CCA GCA TCA CC -39.
Apoptosis ELISA
Cells were plated in 96-well plates and grown in RPMI 1640
containing 11.1 mmol/l glucose until reaching 70% confluence.
The cells were then exposed for 16 h to 0.5% (w/v) BSA with or
without 0.5 mmol/l palmitate at 3.3 and 22.2 mmol/l glucose and
different treatments as indicated in the figure legends. Cells were
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induced DNA degradation were quantified using the Cell Death
ELISA
PLUS assay (Roche Diagnostics, Manheim Germany)
according to the manufacturer’s instructions.
b-cell proliferation
b-Cell proliferation was analyzed by measuring
3H-thymidine
incorporation in INS-1E cells. Cells were seeded in 24-well plates
and grown to 50–60% confluence. Medium was then changed to
RPMI 1640 containing 11.1 mmol/l glucose and 1% BSA. After
24 h, the cells were treated with and without palmitate at 3.3 and
22.2 mmol/lglucose with and withoutrapamycinin the presenceof
1% fetal bovine serum, 1 mCi
3H-thymidine and 10 nmol/l cold
thymidine for 16 h. The cells were then washed with PBS, treated
with 10% trichloroacetic acid for 10 min and repeatedly washed
with 5% trichloroacetic acid, followed by cell solubilization with
0.5 ml 0.1 N NaOH. The solubilized cell solution was neutralized
with HCl, collected into scintillation vials and radioactive counts
measured in a b-counter. Similarly treated cells without radioactive
labeled thymidine, were used for cell counting.
Proinsulin and total protein biosynthesis
For measurement of proinsulin and total protein biosynthesis in
INS-1E cells, 5610
5 cells were seeded in 12-well plates and treated
with 0.5% BSA with and without palmitate at 3.3 and 22.2 mmol/l
glucose with andwithout rapamycin orcycloheximidefor16 h.The
last 2 h of the incubations were performed in KRBH-BSA buffer
containing similar treatments and 10 mCi L-[2, 3, 4, 5-
3H]leucine
(120 Ci/mmol; ARC,St.Louis,MO).After2-hincubation at37uC,
leucine incorporation was terminated by ice-cold wash-out in
glucose-free KRBH-BSA buffer. The cells were then scrapped and
centrifuged and the pellets subjected to immunoprecipitation, as
described [52]. Briefly, the INS-1E cell pellets were suspended in
450 ml 0.2 mol/l glycine buffer containing 0.1% RIA-grade BSA
and 0.5% NP-40, pH 8.8 (GB/NP40 buffer), and subjected to four
freeze-thaw cycles in liquid nitrogen. Each sample (50 ml) was
pretreated with protein A-Sepharose (Sigma) before immunopre-
cipitation with anti-insulin serum (Sigma, product number: I8510),
to correct for nonspecific binding. Comparing the results obtained
by immunprecipitation to those obtained by HPLC analysis
validated the accuracy of the proinsulin biosynthesis analysis (Figure
S4). Total protein biosynthesis was determined by trichloroacetic
acid precipitation [53].
Data presentation and statistical analysis
Data shown are means6SE. Statistical significance of differ-
ences between groups was determined by one-way ANOVA
followed by Newman-Keuls test using the InStat statistical
program from GraphPad Software, Inc. (San Diego, CA). A
paired-sample t test was used when the difference between a
reference (taken as 100%) and a test was analyzed. A P value of less
than 0.05 was considered significant.
Supporting Information
Figure S1 Effects of glucose, palmitate and rapamycin on b-cell
proliferation. INS-1E cells were treated with and without
palmitate at 3.3 and 22.2 mmol/l glucose with and without
rapamycin in the presence of 1% fetal bovine serum, 1 mCi
3H-
thymidine and 10 nmol/l cold thymidine for 16 h. Thymidine
incorporation was determined as described in the Materials and
Methods. Each experiment was performed in triplicates. Results are
expressed as means6SE.
‘ p,0.001 for the difference between the
indicated groups.
Found at: doi:10.1371/journal.pone.0004954.s001 (0.10 MB TIF)
Figure S2 Nutrients and rapamycin effects on IRE1a protein
and mRNA levels at different time points. INS-1E cells were
incubated at 3.3 and 22.2 mmol/l glucose with and without
0.5 mmol/l palmitate and 50 nmol/l rapamycin for 4, 8 and 16 h.
(A) IRE1a protein expression was analyzed by Western blot. A
representative gel of 3 individual experiments is shown; (B)
Quantification of IRE1a mRNA levels under the different
treatment conditions at 4 h. Results are expressed as means6SE
of 4 individual experiments.
Found at: doi:10.1371/journal.pone.0004954.s002 (0.18 MB TIF)
Figure S3 Effect of JNK inhibition on glucose and palmitate-
induced ER stress. INS-1E cells were incubated for 16 h at 3.3 and
22.2 mmol/l glucose with 0.5% BSA with and without 0.5 mmol/
l palmitate and 20 nmol/l of the JNK inhibitor SP600125. The
effect of JNK inhibition on c-Jun, JNK and PERK hosphorylation,
and on CHOP expression was analyzed by Western blot; a
representative gel is presented (A). Quantification of PERK
phosphorylation and CHOP expression is shown in (B). Results
are expressed as means6SE of 4 individual experiments. *
p,0.05,
‘ p,0.001 for the difference between the indicated
groups.
Found at: doi:10.1371/journal.pone.0004954.s003 (0.45 MB TIF)
Figure S4 Comparison of proinsulin biosynthesis measurements
by immunoprecipitation and HPLC. Rat islets were treated with
16.7 mmol/l glucose (G16.7) or 10 mmol/l succinate (SAM) for
1 h followed by metabolic labeling with L-[2, 3, 4, 5-
3H]leucine.
Islet extracts were subjected to either immunoprecipitation using
anti-insulin serum as described in the Material and Methods or
HPLC analysis (for details see Gadot et al, Endocrinology
136:4218–4223, 1995). A representative HPLC profile is shown
above and a comparison between the proinsulin measurements
obtained with the two assays is shown below.
Found at: doi:10.1371/journal.pone.0004954.s004 (0.45 MB TIF)
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